Curriculum Vitae
Dong Xie, M.D.
Chief Surgeon, Department of Thoracic Surgery,
Associate Professor and PhD Supervisor at School of Medicine, Tongji University,
Shanghai, People’s Republic of China
E-mail: xiedong@tongji.edu.cn
Personal Statement
Dong Xie, associate professor, master's degree, PhD supervisor and postdoctoral co-supervisor of Tongji University School of Medicine, administrative deputy director and chief physician of Shanghai Pulmonary Hospital affiliated with Tongji University. He has visited Mayo Clinic Hospital for thoracic surgery in the United States.
Dr. Xie has been engaged in the precision surgical treatment of thoracic tumors and the standardized training and promotion of minimally invasive thoracoscopic techniques at both China and abroad for a long time. He has also participated in the writing of many thoracic surgical consensus, and has promoted the establishment of thoracic surgical diagnostic and treatment standards in China.
He has presided over 14 vertical research projects, including one national-level project and three provincial and ministerial-level projects, and has been granted more than 3 million RMB in personal grants. Dr. Xie has published more than 130 SCI articles, including the international top journals in the field of cardiothoracic surgery, such as Journal of Thoracic Oncology, Journal of Thoracic and Cardiovascular Surgery, European Journal of Cardio-Thoracic Surgery. Furthermore, he is the chief editor of Progress in Neoadjuvant Therapy of Lung Cancer (National Key Publication Planning Project of the 14th Five-Year Plan), Don't Be Alarmed When Encountering Frosted Glass Nodules, and Lung Oncology.
Education
09.2009-06.2013 M.D, Second Military Medical University
09.1999-06.2004 B.S and M.S, School of Medicine, Fudan University
Professional Activities
12.2022-present Chief surgeon, Department of Thoracic Surgery, Shanghai Pulmonary Hospital
12.2015-12.2022 Deputy chief surgeon, Department of Thoracic Surgery, Shanghai Pulmonary Hospital
02.2013-04.2014 Research Fellow, Department of Thoracic Surgery, Mayo Clinic
12.2009-12.2015 Attending Surgeon, Department of Thoracic Surgery, Shanghai Pulmonary Hospital
08.2006-12.2009 Resident, Department of Thoracic Surgery, Shanghai Pulmonary Hospital
Academic Appointments
01.2020- present Associate Professor, Tongji University
Society Activities
Memberships
Deputy Head of Thoracic Surgery Rehabilitation Group, China Medical Association Accelerated Rehabilitation Surgery Branch
Young Editorial Board Member, Chinese Clinical Journal of Thoracic and Cardiovascular Surgery
Young member of Thoracic Surgery Branch, China Association for the Promotion of Medical Science
Member of the Oncology Popularization Committee of the Medical Popularization Branch of the Chinese Medical Doctors' Association
Member of Shanghai Thoracic Surgery Branch, Chinese Physicians Association
Member, CSCO Minimally Invasive Oncology Section
Member, International Association for the Study of Lung Cancer
Member, European Society for Thoracic and Cardiovascular Surgery
Member, European Association of Thoracic Surgeons
Member, American Association of Thoracic Surgeons
Young member of Tumor Target Molecular Committee of Shanghai Medical Association
Honors
Shanghai Pujiang Talent
Outstanding Youth of Shanghai Medical Garden Rising Star
Top Ten Medical Youth of Tongji University
Publications (More than 20)
Corresponding author
[1] Z. Fu, K. Li, H. Wang, Y. Li, J. Zhang, J. Zhou, J. Hu, D. Xie, and D. Ni, Spectral computed tomography-guided radiotherapy of osteosarcoma utilizing BiOI nanosheets. Acta Biomater 166 (2023) 615-626.
[2] Y. Zhong, C. Cai, T. Chen, H. Gui, C. Chen, J. Deng, M. Yang, B. Yu, Y. Song, T. Wang, Y. Chen, H. Shi, D. Xie, C. Chen, and Y. She, PET/CT-based deep learning grading signature to optimize surgical decisions for clinical stage I invasive lung adenocarcinoma and biologic basis under its prediction: a multicenter study. Eur J Nucl Med Mol Imaging (2023).
[3] Y. She, S. Li, J. Deng, Y. Ren, M. Zhao, Y. Zhong, Y. He, Q. Chen, D. Zhao, Y. Zhu, L. Hou, C. Wu, D. Xie, and C. Chen, Clinicopathologic characteristics and prognostic impact of atypical EGFR mutations in completely resected lung adenocarcinoma. Eur J Cancer 177 (2022) 53-62.
[4] C. Li, J. Wu, L. Jiang, L. Zhang, J. Huang, Y. Tian, Y. Zhao, X. Liu, L. Xia, H. E, P. Gao, L. Hou, M. Yang, M. Ma, C. Su, H. Zhang, H. Chen, Y. She, D. Xie, Q. Luo, and C. Chen, The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center study. Cancer Immunol Immunother 72 (2023) 783-794.
[5] L.L. Wu, L.H. Qiu, X. Chen, W.J. Yu, C.W. Li, J.Y. Qian, S.H. Liang, P. Lin, H. Long, L.J. Zhang, Z.X. Li, K. Li, F. Jiang, G.W. Ma, and D. Xie, Reconsidering N component of cancer staging for T1-2N0-2M0 small-cell lung cancer: a retrospective study based on multicenter cohort. Respir Res 24 (2023) 168.
[6] J. Gao, L. Zhang, Z. Li, F. Wang, L. Qiu, X. Dou, C. Li, Y. Zhu, G. Ma, G. Jiang, D. Xie, and C. Chen, UniPortal thoracoscopic pneumonectomy does not compromise perioperative and long-term survival in patients with NSCLC: A retrospective, multicenter, and propensity score matching study. Lung Cancer 159 (2021) 135-144.
[7] J. Deng, M. Zhao, T. Wang, Y. She, J. Wu, H. E, J. Gao, X. Sun, G. Jiang, Y. Zhu, D. Xie, and C. Chen, A modified T categorization for part-solid lesions in Chinese patients with clinical stage I Non-small cell lung cancer. Lung Cancer 145 (2020) 33-39.
[8] L.L. Wu, W.T. Chen, C.W. Li, S.H. Song, S.Q. Xu, S.P. Wan, Z.Y. Liu, W.K. Lin, K. Li, Z.X. Li, and D. Xie, The Construction and Validation of Nomogram to Predict the Prognosis with Small-Cell Lung Cancer Followed Surgery. Cancers (Basel) 14 (2022).
[9] L.L. Wu, J.Y. Qian, C.W. Li, Y. Zhang, W.K. Lin, K. Li, Z.X. Li, and D. Xie, The Clinical and Prognostic Characteristics of Primary Salivary Gland-Type Carcinoma in the Lung: A Population-Based Study. Cancers (Basel) 14 (2022).
[10] J.Y. Qian, Y. Hao, H.H. Yu, L.L. Wu, Z.Y. Liu, Q. Peng, Z.X. Li, K. Li, Y. Liu, R.R. Wang, and D. Xie, A Novel Systematic Oxidative Stress Score Predicts the Survival of Patients with Early-Stage Lung Adenocarcinoma. Cancers (Basel) 15 (2023).
[11] F. Wang, H. Su, H. E, L. Hou, M. Yang, L. Xu, J. Gao, M. Zhao, J. Wu, J. Deng, X. Xie, Y. Zhong, Y. Li, T. Wang, C. Wu, D. Xie, and C. Chen, Reconsidering T component of cancer staging for T3/T4 non-small-cell lung cancer with additional nodule. Ther Adv Med Oncol 14 (2022) 17588359221130502.
[12] L.L. Wu, S.H. Liang, F. Jiang, L.H. Qiu, X. Chen, W.J. Yu, C.W. Li, J.Y. Qian, Y.Y. Huang, P. Lin, H. Long, Z.X. Li, K. Li, G.W. Ma, and D. Xie, The postoperative prognosis of skip-N2 metastasis is favorable in small-cell lung carcinoma patients with pathological N2 classification: a propensity-score-adjusted retrospective multicenter study. Ther Adv Med Oncol 15 (2023) 17588359221146134.
[13] K. Li, L.L. Wu, H. Wang, H. Cheng, H.M. Zhuo, Y. Hao, Z.Y. Liu, C.W. Li, J.Y. Qian, Z.X. Li, D. Xie, and C. Chen, The characterization of tumor microenvironment infiltration and the construction of predictive index based on cuproptosis-related gene in primary lung adenocarcinoma. Front Oncol 12 (2022) 1011568.
[14] L.L. Wu, C.W. Li, K. Li, L.H. Qiu, S.Q. Xu, W.K. Lin, G.W. Ma, Z.X. Li, and D. Xie, The Difference and Significance of Parietal Pleura Invasion and Rib Invasion in Pathological T Classification With Non-Small Cell Lung Cancer. Front Oncol 12 (2022) 878482.
[15] J.Y. Qian, L.L. Wu, L.Y. Zhang, K. Li, Z.X. Li, Y. Zhao, and D. Xie, Prognostic evaluation of stage I lung adenocarcinoma based on systematic inflammatory response. JNCI Cancer Spectr (2023).
[16] B. He, Y. Song, L. Wang, T. Wang, Y. She, L. Hou, L. Zhang, C. Wu, B.A. Babu, U. Bagci, T. Waseem, M. Yang, D. Xie, and C. Chen, A machine learning-based prediction of the micropapillary/solid growth pattern in invasive lung adenocarcinoma with radiomics. Transl Lung Cancer Res 10 (2021) 955-964.
[17] B.X. He, Y.F. Zhong, Y.B. Zhu, J.J. Deng, M.J. Fang, Y.L. She, T.T. Wang, Y. Yang, X.W. Sun, L. Belluomini, S. Watanabe, D. Dong, J. Tian, and D. Xie, Deep learning for predicting immunotherapeutic efficacy in advanced non-small cell lung cancer patients: a retrospective study combining progression-free survival risk and overall survival risk. Transl Lung Cancer Res 11 (2022) 670-685.
[18] H. Su, C. Gu, Y. She, L. Xu, P. Yang, H. Xie, S. Zhao, C. Wu, D. Xie, and C. Chen, Predictors of upstage and treatment strategies for stage IA lung cancers after sublobar resection for adenocarcinoma in situ and minimally invasive adenocarcinoma. Transl Lung Cancer Res 10 (2021) 32-44.
[19] J. Deng, Y. She, M. Yang, L. Zhang, D. Xie, and C. Chen, Radiomics: a potential biomarker for N2 malignancy in clinical stage I lung adenocarcinoma. Transl Lung Cancer Res 9 (2020) 1623-1624.
[20] L.L. Wu, C.W. Li, W.K. Lin, L.H. Qiu, and D. Xie, Incidence and survival analyses for occult lung cancer between 2004 and 2015: a population-based study. BMC Cancer 21 (2021) 1009.
[21] L.L. Wu, W.K. Lin, J.Y. Qian, S.S. Ma, M.J. Li, K. Li, Z.X. Li, G. Lan, and D. Xie, Prognostic assessment of lung adenocarcinoma patients with early-staging diseases: a nomogram based on coagulation-related factors. Eur J Cardiothorac Surg 64 (2023).
First author
[1] D. Xie, R. Marks, M. Zhang, G. Jiang, A. Jatoi, Y.I. Garces, A. Mansfield, J. Molina, and P. Yang, Nomograms Predict Overall Survival for Patients with Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers. J Thorac Oncol 10 (2015) 1213-20.
[2] D. Xie, J. Deng, D. Gonzalez-Rivas, Y. Zhu, L. Jiang, G. Jiang, and C. Chen, Comparison of video-assisted thoracoscopic surgery with thoracotomy in bronchial sleeve lobectomy for centrally located non-small cell lung cancer. J Thorac Cardiovasc Surg 161 (2021) 403-413.e2.
[3] D. Xie, J. Ding, X. Zhou, K. Fei, X. You, and G. Jiang, Simplified carinal wedge resection and reconstruction. Ann Thorac Surg 98 (2014) 731-3.
[4] D. Xie, H. Xie, X. You, C. Chen, and G. Jiang, Pulmonary sequestration with aberrant arteries arising from the renal artery and the internal thoracic artery. Ann Thorac Surg 96 (2013) e131.
[5] D. Xie, C. Deschamps, R.K. Shen, B. Deng, J.A. Wampfler, S.D. Cassivi, F.C. Nichols, M.S. Allen, D.A. Wigle, and P. Yang, Bilobectomy Versus Lobectomy for Non-Small Cell Lung Cancer: A Comparative Study of Outcomes, Long-Term Survival, and Quality of Life. Ann Thorac Surg 100 (2015) 242-50.
[6] D. Xie, T.T. Wang, S.J. Huang, J.J. Deng, Y.J. Ren, Y. Yang, J.Q. Wu, L. Zhang, K. Fei, X.W. Sun, Y.L. She, and C. Chen, Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma. Transl Lung Cancer Res 9 (2020) 1112-1123.
[7] D. Xie, J. Wu, X. Hu, D. Gonzalez-Rivas, Y. She, Q. Chen, Y. Zhu, G. Jiang, and C. Chen, Uniportal versus multiportal video-assisted thoracoscopic surgery does not compromise the outcome of segmentectomy. Eur J Cardiothorac Surg 59 (2021) 650-657.
[8] D. Xie, M.S. Allen, R. Marks, G. Jiang, Z. Sun, F. Nichols, M. Zhang, C. Chen, M.C. Aubry, A. Jatoi, Y.I. Garces, A. Mansfield, D. Wigle, J. Molina, C. Deschamps, and P. Yang, Nomogram prediction of overall survival for patients with non-small-cell lung cancer incorporating pretreatment peripheral blood markers. Eur J Cardiothorac Surg 53 (2018) 1214-1222.
[9] D. Xie, Y. Zhong, J. Deng, Y. She, L. Zhang, J. Fan, G. Jiang, Y. Zhu, L. Jiang, and C. Chen, Comparison of uniportal video-assisted thoracoscopic versus thoracotomy bronchial sleeve lobectomy with pulmonary arterioplasty for centrally located non-small-cell lung cancer. Eur J Cardiothorac Surg 59 (2021) 978-986.
